Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis
NCT00470171
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
98
Enrollment
INDUSTRY
Sponsor class
Conditions
Serum Levels of ALAT Transaminases
Serum Markers for Fibrosis and Hepatic Inflammation
Interventions
DRUG:
Ursodesoxycholic acid
Sponsor
Axcan Pharma